Clinical Significance of Prothrombin Time in Cholangiocarcinoma Patients with Surgeries

Figure 2

Recurrence-free survival in patients with cholangiocarcinoma according to PT levels (P=0.0151) (PT, prothrombin time; RFS, recurrence-free survival).